ITRM
Iterum Therapeutics Plc
NASDAQ · Pharmaceuticals
$0.30
+0.02 (+5.89%)
Open$0.30
Previous Close$0.29
Day High$0.32
Day Low$0.29
52W High$22.25
52W Low$13.26
Volume—
Avg Volume245.4K
Market Cap15.96M
P/E Ratio24.60
EPS$0.83
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+7,853.6% upside
Current
$0.30
$0.30
Target
$24.02
$24.02
$15.49
$24.02 avg
$28.73
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.84M | 2.52M | 2.36M |
| Net Income | 737.1K | 595.8K | 463.7K |
| Profit Margin | 25.9% | 23.7% | 19.6% |
| EBITDA | 1.27M | 1.08M | 1.08M |
| Free Cash Flow | 617.3K | 603.4K | 596.2K |
| Rev Growth | +5.6% | +6.9% | +16.3% |
| Debt/Equity | 0.35 | 0.29 | 0.29 |
Dividend
Dividend Yield1.53%
Annual Dividend$0.31
Payout Ratio37.9%
Frequencyquarterly
Ex-DividendMar 14, 2026
Pay DateMar 25, 2026
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |